(Q43787469)

26 November 2017

title

Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production (English)

1 reference

26 November 2017

S Heidt

1

1 reference

26 November 2017

D L Roelen

2

1 reference

26 November 2017

C Eijsink

3

1 reference

26 November 2017

M Eikmans

4

1 reference

26 November 2017

F H J Claas

5

1 reference

26 November 2017

A Mulder

6

1 reference

26 November 2017

publication date

1 October 2009

1 reference

Clinical and Experimental Immunology

26 November 2017

published in

1 reference

26 November 2017

volume

158

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

99-105

1 reference

Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin

26 November 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Rituximab and intravenous immune globulin for desensitization during renal transplantation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

The effect of desensitization protocols on human splenic B-cell populations in vivo.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Current approaches to treatment of antibody-mediated rejection

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Modulation of mononuclear phagocyte function by intravenous gamma-globulin

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

The use of intravenous immune globulin in immunodeficiency diseases

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2759064

Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)

29 September 2018

1 reference

12 December 2020

Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG

1 reference

12 December 2020

Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation

1 reference

12 December 2020

Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use

1 reference

12 December 2020

The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system

1 reference

12 December 2020

Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig

1 reference

12 December 2020

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

1 reference

12 December 2020

Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients

1 reference

12 December 2020

Suppression of Cytokine-Dependent Human T-Cell Proliferation by Intravenous Immunoglobulin

1 reference

12 December 2020

Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro

1 reference

12 December 2020

Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT)

1 reference

12 December 2020

Intravenous immunoglobulin inhibits IgE production in human B lymphocytes

1 reference

12 December 2020

IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity

1 reference

12 December 2020

Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells

1 reference

12 December 2020

10.1111/J.1365-2249.2009.03996.X

Identifiers

DOI

1 reference

26 November 2017

0 references

1 reference